Capricor Therapeutics (CAPR) Financials: Revenue & Earnings
CAPR$6.32+0.21 +3.52%
$365.71M
Market Cap
-2.41
P/E
30.66
Forward P/E
68
Score
Capricor Therapeutics (CAPR) Financials: Revenue & Earnings
CAPR price $6.32 +0.21 +3.52%
- Ticker
- CAPR
- Price
- $6.32
- Change
- +0.21 +3.52%
- Market cap ?
- $365.71M
- P/E ?
- -2.41
- Forward P/E ?
- 30.66
- Dividend yield ?
- 0.00%
- Beta ?
- 0.53
- Sector
- Healthcare
- Industry
- Biotechnology
- Stocklytics score
- 68
- Value
- 61
- Quality
- 42
- Growth
- 100
Stocklytics score rationale: value 61, quality 42, growth 100.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 3190000 | 2666000 | 1671000 | 1005028 | 310250 | 244898 | 2551469 | 25178066 | 22270465 | 0 |
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003…
Fair value
CAPR fair value $7.59. Price $6.32. Price is 17% below fair value.
Fair value is an estimate of what one share is worth if future cash flows arrive as modeled. It is not a forecast of the share price. How discounted cash flow works.
Calculated with a 10-year free-cash-flow discount. Starting free cash flow 3.05M. Growth 20.00%. When analyst earnings forecasts are available, free cash flow in those years is forecast earnings times the company's usual conversion of earnings into free cash flow, kept between 60% and 130%. Years with fewer than 3 analyst estimates are left out. Growth then fades in a straight line to terminal growth by year 10, starting from the last well-covered year's growth, or from the pace across those years when the final year slows sharply, kept between 0% and 20%. Without those forecasts, year-1 growth is analyst revenue growth for the next full fiscal year, or 5-year historical revenue growth when that forecast is missing, held for five years, then fading in a straight line to terminal growth by year 10. Terminal growth 3.00%. Discount rate 8.70% (beta 0.8). Beta is kept between 0.8 and 2.0, which on its own would make the discount rate 8.7% to 15.3%. The rate is then capped at 12%. A cap is used because a discount above 12% pushes higher-beta stocks further from the price. The discount rate stays at least 5 percentage points above terminal growth. Shares 57.91M. Net debt -269.90M. The earnings value is next-12-months earnings per share, or trailing earnings when that forecast is missing, times the stock's own 10-year median P/E, kept between 8 and 40. Fewer than five years of history uses the sector's typical P/E. Fair value is the average of the cash-flow value and the earnings value when both exist. Model uncertainty is high when fair value is more than 60% from the price, or when most of the cash-flow value sits after year 10.
Earnings
| Date | EPS actual | EPS estimate | Revenue | Revenue estimate |
|---|---|---|---|---|
| 2026-11-09 | — | -0.13 | — | 41.71M |
| 2026-08-14 | -0.70 | -0.59 | — | 2.08M |
| 2026-05-12 | -0.59 | -0.55 | — | 40.00M |
| 2026-03-12 | -0.62 | -0.51 | — | 525.00K |
| 2025-11-10 | -0.54 | -0.54 | — | 600.00K |
| 2025-08-11 | -0.57 | -0.48 | — | 480.00K |
| 2025-05-13 | -0.53 | -0.33 | — | 3.16M |
| 2025-03-19 | -0.16 | -0.31 | 11.13M | 5.50M |
| 2024-11-13 | -0.38 | -0.36 | 2.26M | 9.87M |
| 2024-08-07 | -0.35 | -0.36 | 3.97M | 3.58M |
| 2024-05-13 | -0.31 | -0.11 | 4.91M | 9.70M |
| 2024-02-29 | -0.02 | -0.09 | 12.09M | 10.60M |
| 2023-11-14 | -0.25 | -0.29 | 6.19M | 10.90M |
| 2023-08-07 | -0.29 | -0.35 | 3.92M | 1.50M |
| 2023-05-11 | -0.31 | -0.32 | 2.99M | 500.00K |
| 2023-03-15 | -0.31 | -0.33 | 959.90K | 10.00K |
| 2022-11-10 | -0.26 | -0.29 | 1.59M | 420.00K |
| 2022-08-10 | -0.29 | -0.25 | — | 390.00K |
| 2022-05-10 | -0.32 | — | — | — |
| 2022-03-10 | -0.26 | -0.19 | -244.65K | — |
| 2021-11-09 | -0.17 | -0.22 | — | 210.00K |
| 2021-08-12 | -0.21 | -0.23 | 204.08K | 221.83K |
| 2021-05-13 | -0.23 | — | 40.82K | — |
| 2021-03-11 | -0.21 | -0.20 | 57.83K | 210.00K |
| 2020-11-12 | -0.20 | — | 16.86K | — |
| 2020-08-06 | -0.23 | -0.37 | 49.86K | 80.21K |
| 2020-05-14 | -0.30 | -0.33 | 185.69K | 204.26K |
| 2020-03-18 | -0.34 | -0.34 | 222.10K | 222.10K |
| 2019-11-07 | -0.43 | -0.70 | 142.07K | 231.28K |
| 2019-08-06 | -0.59 | -0.80 | 410.35K | 556.41K |
| 2019-05-13 | -0.80 | -1.10 | 230.50K | — |
| 2019-03-28 | -1.10 | -1.60 | 648.08K | 942.66K |
| 2018-11-13 | -1.40 | -1.45 | 219.25K | 227.08K |
| 2018-08-09 | -1.40 | -1.25 | 403.96K | 357.14K |
| 2018-05-10 | -1.40 | -1.20 | 400.07K | 342.86K |
| 2018-03-14 | -1.10 | -1.00 | 475.80K | 436.36K |
| 2017-11-08 | -1.20 | -1.90 | 313.27K | 490.83K |
| 2017-08-10 | -1.60 | -1.80 | 996.46K | 1.12M |
| 2017-05-15 | -1.70 | -1.50 | 880.81K | 776.47K |
| 2017-03-15 | -1.40 | -2.40 | 683.60K | 1.30M |
Dividends
Yield 0.00%. Payout ratio 0.00%. Frequency —.
Safety score 37/100 · Watch. Payout ratio is 0% of earnings. Free-cash-flow coverage is not available, so this part stays neutral. No dividend history was found. There is no dividend yield.
| Ex-date | Dividend | Record | Payment | Frequency |
|---|---|---|---|---|
| No data yet. | ||||
Insider trades
| Date | Insider | Action | Shares | Price | Value |
|---|---|---|---|---|---|
| 2026-06-25 | Krasney Karen | Buy | 24.10K | $3.18 | 76.64K |
| 2026-06-25 | Krasney Karen | Sell | 24.10K | $3.18 | 76.64K |
| 2026-06-25 | Krasney Karen | Sell | 24.10K | $30.38 | 732.16K |
| 2026-06-25 | Bergmann Anthony | Sell | 24.10K | $3.18 | 76.64K |
| 2026-06-25 | Bergmann Anthony | Buy | 24.10K | $3.18 | 76.64K |
| 2026-06-25 | Bergmann Anthony | Sell | 24.10K | $30.38 | 732.16K |
| 2026-06-24 | Krasney Karen | Sell | 400 | $3.18 | 1.27K |
| 2026-06-24 | Krasney Karen | Buy | 400 | $3.18 | 1.27K |
| 2026-06-24 | Krasney Karen | Sell | 400 | $30.00 | 12.00K |
| 2026-06-24 | Bergmann Anthony | Sell | 400 | $3.18 | 1.27K |
| 2026-06-24 | Bergmann Anthony | Buy | 400 | $3.18 | 1.27K |
| 2026-06-24 | Bergmann Anthony | Sell | 400 | $30.00 | 12.00K |
| 2026-06-22 | Krasney Karen | Sell | 500 | $3.18 | 1.59K |
| 2026-06-22 | Krasney Karen | Buy | 500 | $3.18 | 1.59K |
| 2026-06-22 | Bergmann Anthony | Sell | 500 | $3.18 | 1.59K |
| 2026-06-22 | Bergmann Anthony | Buy | 500 | $3.18 | 1.59K |
| 2026-05-26 | Maurer Michael T | Buy | 80.00K | $29.36 | 2.35M |
| 2026-05-25 | Maurer Michael T | Other | 0 | — | — |
| 2026-05-18 | Bergmann Anthony | Buy | 3.00K | $1.39 | 4.17K |
| 2026-05-18 | Bergmann Anthony | Sell | 3.00K | $1.39 | 4.17K |
| 2026-05-13 | Litvack Frank | Buy | 3.94K | $1.39 | 5.47K |
| 2026-05-13 | Litvack Frank | Sell | 3.94K | $1.39 | 5.47K |
| 2026-05-01 | Krasney Karen | Sell | 25.00K | $3.18 | 79.50K |
| 2026-05-01 | Krasney Karen | Buy | 25.00K | $3.18 | 79.50K |
| 2026-05-01 | Krasney Karen | Sell | 25.00K | $31.70 | 792.55K |
| 2026-05-01 | Bergmann Anthony | Sell | 25.00K | $3.18 | 79.50K |
| 2026-05-01 | Bergmann Anthony | Buy | 25.00K | $3.18 | 79.50K |
| 2026-05-01 | Bergmann Anthony | Sell | 25.00K | $31.70 | 792.54K |
| 2026-04-02 | Sabar Karimah Es | Buy | 7.53K | $3.18 | 23.94K |
| 2026-04-02 | Sabar Karimah Es | Sell | 7.53K | $3.18 | 23.94K |
| 2026-04-02 | Sabar Karimah Es | Sell | 7.53K | $32.00 | 240.93K |
| 2026-04-01 | Sabar Karimah Es | Buy | 53.73K | $4.86 | 261.15K |
| 2026-04-01 | Sabar Karimah Es | Sell | 53.73K | $31.03 | 1.67M |
| 2026-04-01 | Sabar Karimah Es | Sell | 53.73K | $4.86 | 261.15K |
| 2026-03-31 | Krasney Karen | Sell | 2.82K | $3.18 | 8.96K |
| 2026-03-31 | Krasney Karen | Sell | 21.49K | $3.74 | 80.37K |
| 2026-03-31 | Krasney Karen | Buy | 2.82K | $3.18 | 8.96K |
| 2026-03-31 | Krasney Karen | Buy | 21.49K | $3.74 | 80.37K |
| 2026-03-31 | Krasney Karen | Buy | 693 | $1.39 | 963 |
| 2026-03-31 | Krasney Karen | Sell | 25.00K | $30.12 | 752.93K |
| 2026-03-31 | Krasney Karen | Sell | 693 | $1.39 | 963 |
| 2026-03-31 | Sabar Karimah Es | Buy | 61.27K | $4.86 | 297.75K |
| 2026-03-31 | Sabar Karimah Es | Sell | 61.27K | $4.86 | 297.75K |
| 2026-03-31 | Sabar Karimah Es | Sell | 61.27K | $30.17 | 1.85M |
| 2026-03-31 | Bergmann Anthony | Sell | 25.00K | $3.18 | 79.50K |
| 2026-03-31 | Bergmann Anthony | Buy | 25.00K | $3.18 | 79.50K |
| 2026-03-31 | Bergmann Anthony | Sell | 25.00K | $30.13 | 753.15K |
| 2026-01-05 | Marban Linda | Buy | 100.00K | $24.81 | 2.48M |
| 2026-01-05 | Marban Linda | Buy | 50.00K | $24.81 | 1.24M |
| 2026-01-05 | Marban Linda | Buy | 7.50K | — | — |
| 2026-01-05 | Bergmann Anthony | Buy | 25.00K | $24.81 | 620.25K |
| 2026-01-05 | Bergmann Anthony | Buy | 2.50K | — | — |
| 2026-01-05 | Krasney Karen | Buy | 22.50K | $24.81 | 558.23K |
| 2026-01-05 | Auwaerter Paul Gisbert | Buy | 15.50K | $24.81 | 384.56K |
| 2026-01-05 | Auwaerter Paul Gisbert | Buy | 5.42K | $24.81 | 134.47K |
| 2026-01-05 | Auwaerter Paul Gisbert | Buy | 1.36K | $24.81 | 33.74K |
| 2026-01-05 | Kelliher Mike | Buy | 15.50K | $24.81 | 384.56K |
| 2026-01-05 | Gotwals Philip J | Buy | 15.50K | $24.81 | 384.56K |
| 2026-01-05 | Sabar Karimah Es | Buy | 15.50K | $24.81 | 384.56K |
| 2026-01-05 | Musket David B | Buy | 15.50K | $24.81 | 384.56K |
| 2026-01-05 | DUNBAR GEORGE W JR | Buy | 15.50K | $24.81 | 384.56K |
| 2026-01-05 | Litvack Frank | Buy | 50.00K | $24.81 | 1.24M |
| 2025-12-30 | Krasney Karen | Buy | 2.50K | $1.39 | 3.47K |
| 2025-12-30 | Krasney Karen | Sell | 2.50K | $1.39 | 3.47K |
| 2025-12-19 | DUNBAR GEORGE W JR | Buy | 3.00K | $1.39 | 4.17K |
| 2025-12-19 | DUNBAR GEORGE W JR | Sell | 3.00K | $1.39 | 4.17K |
| 2025-03-05 | Marban Linda | Sell | 12.50K | — | — |
| 2025-03-03 | Marban Linda | Buy | 25.00K | $1.39 | 34.75K |
| 2025-03-03 | Marban Linda | Sell | 25.00K | $1.39 | 34.75K |
| 2025-03-03 | Bergmann Anthony | Buy | 2.50K | $1.39 | 3.47K |
| 2025-03-03 | Bergmann Anthony | Sell | 2.50K | $1.39 | 3.47K |
| 2025-03-03 | Litvack Frank | Buy | 25.00K | $1.39 | 34.75K |
| 2025-03-03 | Litvack Frank | Sell | 2.54K | $13.67 | 34.76K |
| 2025-03-03 | Litvack Frank | Sell | 25.00K | $1.39 | 34.75K |
| 2025-03-03 | DUNBAR GEORGE W JR | Buy | 750 | $1.39 | 1.04K |
| 2025-03-03 | DUNBAR GEORGE W JR | Sell | 750 | $1.39 | 1.04K |
| 2025-02-27 | COLLIER EARL M JR | Buy | 750 | $1.39 | 1.04K |
| 2025-02-27 | COLLIER EARL M JR | Sell | 750 | $1.39 | 1.04K |
| 2025-01-02 | Litvack Frank | Buy | 50.00K | $14.96 | 748.00K |
| 2025-01-02 | Bergmann Anthony | Buy | 75.00K | $14.96 | 1.12M |
| 2025-01-02 | Bergmann Anthony | Buy | 6.17K | $14.96 | 92.30K |
| 2025-01-02 | Bergmann Anthony | Buy | 3.34K | — | — |
| 2025-01-02 | Krasney Karen | Buy | 60.00K | $14.96 | 897.60K |
| 2025-01-02 | Marban Linda | Buy | 210.00K | $14.96 | 3.14M |
| 2025-01-02 | Marban Linda | Buy | 34.96K | $14.96 | 523.03K |
| 2025-01-02 | Kelliher Mike | Buy | 11.94K | $14.96 | 178.62K |
| 2025-01-02 | Kelliher Mike | Buy | 5.75K | $14.96 | 86.02K |
| 2025-01-02 | Kelliher Mike | Buy | 1.44K | $14.96 | 21.54K |
| 2025-01-02 | Auwaerter Paul Gisbert | Buy | 11.94K | $14.96 | 178.62K |
| 2025-01-02 | Auwaerter Paul Gisbert | Buy | 5.75K | $14.96 | 86.02K |
| 2025-01-02 | Auwaerter Paul Gisbert | Buy | 1.44K | $14.96 | 21.54K |
| 2025-01-02 | Sabar Karimah Es | Buy | 11.94K | $14.96 | 178.62K |
| 2025-01-02 | Sabar Karimah Es | Buy | 5.75K | $14.96 | 86.02K |
| 2025-01-02 | Sabar Karimah Es | Buy | 2.52K | $14.96 | 37.70K |
| 2025-01-02 | Musket David B | Buy | 11.94K | $14.96 | 178.62K |
| 2025-01-02 | Musket David B | Buy | 6.48K | $14.96 | 96.94K |
| 2025-01-02 | Musket David B | Buy | 5.75K | $14.96 | 86.02K |
| 2025-01-02 | DUNBAR GEORGE W JR | Buy | 11.94K | $14.96 | 178.62K |
| 2025-01-02 | DUNBAR GEORGE W JR | Buy | 5.75K | $14.96 | 86.02K |
| 2025-01-02 | DUNBAR GEORGE W JR | Buy | 3.60K | $14.96 | 53.86K |
Institutional holders
Latest filed quarter: Q2 2026.
Institutions holding: 196, holders +1 vs prior quarter. Ownership 68.17%.
| Holder | Shares | Change | Change % | Value |
|---|---|---|---|---|
| BLACKROCK, INC. | 4.15M | 723.25K | +21.14% | 99.81M |
| TANG CAPITAL MANAGEMENT LLC | 4.10M | 700.00K | +20.59% | 98.73M |
| MONTANOVA CAPITAL, LLC | 4.09M | 274.18K | +7.18% | 98.55M |
| STATE STREET CORP | 3.40M | 1.22M | +55.70% | 81.80M |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.30M | 269.94K | +13.31% | 55.33M |
| GOLDMAN SACHS GROUP INC | 1.58M | 666.15K | +73.05% | 38.00M |
| RA CAPITAL MANAGEMENT, L.P. | 1.51M | 0 | 0.00% | 36.31M |
| BOXER CAPITAL MANAGEMENT, LLC | 1.40M | 805.16K | +136.47% | 33.60M |
| GEODE CAPITAL MANAGEMENT, LLC | 1.37M | 253.96K | +22.71% | 33.05M |
| FMR LLC | 1.14M | 365.08K | +47.25% | 27.40M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 1.06M | 1.01M | +1894.75% | 25.64M |
| PERCEPTIVE ADVISORS LLC | 1.00M | 1.00M | New | 24.08M |
| CITADEL ADVISORS LLC | 814.44K | 477.94K | +142.03% | 19.61M |
| MERCER GLOBAL ADVISORS INC /ADV | 802.73K | 399.73K | +99.19% | 19.33M |
| SOLEUS CAPITAL MANAGEMENT, L.P. | 761.74K | 761.74K | New | 18.34M |
| MORGAN STANLEY | 684.51K | 260.70K | +61.51% | 16.48M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 636.09K | 256.87K | +67.74% | 15.32M |
| UBS GROUP AG | 619.66K | 247.68K | +66.58% | 14.92M |
| DG CAPITAL MANAGEMENT, LLC | 611.60K | 219.50K | +55.98% | 14.73M |
| IKARIAN CAPITAL, LLC | 604.22K | 254.22K | +72.63% | 14.55M |
| DIADEMA PARTNERS LP | 534.40K | 455.55K | +577.73% | 12.87M |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 528.00K | 474.62K | +889.23% | 12.71M |
| NORTHERN TRUST CORP | 503.53K | 85.99K | +20.59% | 12.13M |
| PERCEPTIVE ADVISORS LLC | 500.00K | 500.00K | New | 12.04M |
| BALYASNY ASSET MANAGEMENT L.P. | 486.84K | 189.71K | +63.85% | 11.72M |
Earnings and financials
Capricor Therapeutics, Inc. (CAPR) trades at $6.32, with a market cap of $365.71M and a trailing P/E of -2.41. Revenue below is the annual history on file. It describes what the business has already reported. It is not a forecast and it is not a recommendation.
Financials
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 3190000 | 2666000 | 1671000 | 1005028 | 310250 | 244898 | 2551469 | 25178066 | 22270465 | 0 |
Insights · Dividends · Forecast · Financials · Learn